Quinapril Hydrochloride (Carilion Materials Management)


Welcome to the PulseAid listing for the Quinapril Hydrochloride drug offered from Carilion Materials Management. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: quinapril hydrochloride
SUBSTANCE NAME: QUINAPRIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 1991-11-19
END MARKETING DATE: 0000-00-00


Quinapril Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionQuinapril Hydrochloride from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 1991-11-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-1020_b0603993-03f4-4b9c-b86c-abe5913a7a87
PRODUCT NDC: 68151-1020
APPLICATION NUMBER: NDA019885

Other QUINAPRIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementQuinapril Hydrochloride